Nice to see your more upbeat post. Agree with most. If the company is sold, we might see 35 or more a share. I believe if we sold the rights to the 3 Bs and P, we could get there too. The company could then introduce the many other B applications, take K through trials, their autism candidate among many others. It could be very interesting but need to get the first deal under their belt and complete the Aspire financing goals that should be very easy to complete if not already done.